CCME Global Limited Allots Equity Shares via Preferential Issue
CCME Global Limited, formerly known as Genesis IBRC India Limited, announced the allotment of 3,22,50,000 equity shares on March 26, 2026. The shares, with a face value of INR 10 each, were allotted at par against a total consideration of INR 32,25,00,000.The preferential issue was made to a mix of promoters and non-promoters through a private placement basis. The shareholding breakdown is as follows:
| Allottee Name | Number of Equity Shares | Category |
|---|---|---|
| Mr. Padmanaban Krishnamoorthy | 2,00,00,000 | Promoter / Individual |
| Ms. V. Varalakshmi | 40,00,000 | Promoter / Individual |
| Mr. Noor Muhammed Habibullah | 20,00,000 | Non-Promoter / Individual |
| Mr. Suresh Kumar Ramani | 20,00,000 | Non-Promoter / Individual |
| Mr. Vidhu Mohan Pillai | 20,00,000 | Non-Promoter / Individual |
| Dhanesh Advisory LLP | 11,00,000 | Non-Promoter / Non-Individual (Body Corporate) |
| Mr. Ajay Sangani | 2,00,000 | Non-Promoter / Individual |
| Mr. Kaushal Ruparel | 7,00,000 | Non-Promoter / Individual |
| Mr. Nandlal Chaturvedi | 1,00,000 | Non-Promoter / Individual |
| Ms. Poonam Chaturvedi | 50,000 | Non-Promoter / Individual |
| Mr. Ravindranath Rajaram | 1,00,000 | Non-Promoter / Individual |
| TOTAL | 3,22,50,000 |
The new equity shares rank pari passu with existing shares, entitling them to the same rights and benefits.
Following the allotment, the company’s issued, subscribed, and paid-up capital stands at 4,52,50,000 equity shares with a total value of INR 45,25,00,000. The preferential issue was approved by shareholders on March 5, 2026. The issue price was INR 10 per share, based on a valuation report dated January 28, 2026. Eleven investors participated in the preferential allotment.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.